IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

EMA Adopts Procedure to Deal with GMP Non-Compliance Information from Other Authorities

7:17 AM MDT | June 12, 2012 | Deepti Ramesh

The European Medicines Agency (EMA; London) says it has adopted a procedure for dealing with all circumstances of serious GMP non-compliance information originating from third country authorities and international organizations. The Information may refer to active pharmaceutical ingredients (API), finished product or investigational medicinal products (IMP) manufacturers, and quality control labs located either in Europe or elsewhere. The procedure, which was adopted in May 2012 and is expected to come into force in November 2012, is necessary to ensure a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa